243 related articles for article (PubMed ID: 28066721)
1. Incorporation of GM-CSF or CD40L Enhances the Immunogenicity of Hantaan Virus-Like Particles.
Cheng LF; Wang F; Zhang L; Yu L; Ye W; Liu ZY; Ying QK; Wu XA; Xu ZK; Zhang FL
Front Cell Infect Microbiol; 2016; 6():185. PubMed ID: 28066721
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of CD40 ligand or granulocyte-macrophage colony stimulating factor into Hantaan virus (HTNV) virus-like particles significantly enhances the long-term immunity potency against HTNV infection.
Dong Y; Ma T; Zhang X; Ying Q; Han M; Zhang M; Yang R; Li Y; Wang F; Liu R; Wu X
J Med Microbiol; 2019 Mar; 68(3):480-492. PubMed ID: 30657443
[TBL] [Abstract][Full Text] [Related]
3. Construction and immunological characterization of CD40L or GM-CSF incorporated Hantaan virus like particle.
Ying Q; Ma T; Cheng L; Zhang X; Truax AD; Ma R; Liu Z; Lei Y; Zhang L; Ye W; Zhang F; Xu Z; Shang L; Liu R; Wang F; Wu X
Oncotarget; 2016 Sep; 7(39):63488-63503. PubMed ID: 27542281
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.
Skountzou I; Quan FS; Gangadhara S; Ye L; Vzorov A; Selvaraj P; Jacob J; Compans RW; Kang SM
J Virol; 2007 Feb; 81(3):1083-94. PubMed ID: 17108046
[TBL] [Abstract][Full Text] [Related]
5. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
6. Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design.
Liu WC; Liu YY; Chen TH; Liu CC; Jan JT; Wu SC
Antiviral Res; 2016 Sep; 133():110-8. PubMed ID: 27491439
[TBL] [Abstract][Full Text] [Related]
7. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
8. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
[TBL] [Abstract][Full Text] [Related]
9. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
[TBL] [Abstract][Full Text] [Related]
10. Influenza virus-like particles composed of conserved influenza proteins and GPI-anchored CCL28/GM-CSF fusion proteins enhance protective immunity against homologous and heterologous viruses.
Liu J; Ren Z; Wang H; Zhao Y; Wilker PR; Yu Z; Sun W; Wang T; Feng N; Li Y; Wang H; Ji X; Li N; Yang S; He H; Qin C; Gao Y; Xia X
Int Immunopharmacol; 2018 Oct; 63():119-128. PubMed ID: 30081250
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
Hooper JW; Custer DM; Thompson E; Schmaljohn CS
J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
[TBL] [Abstract][Full Text] [Related]
12. Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7.
Li K; Li PY; Wu XA; Zhang L; Liu ZY; Yu L; Zhang L; Cheng LF; Bai WT; Zhang FL; Xu ZK
Int J Mol Med; 2013 Sep; 32(3):709-16. PubMed ID: 23783439
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs.
Feng H; Zhang H; Deng J; Wang L; He Y; Wang S; Seyedtabaei R; Wang Q; Liu L; Galipeau J; Compans RW; Wang BZ
Sci Rep; 2015 Jul; 5():11856. PubMed ID: 26150163
[TBL] [Abstract][Full Text] [Related]
14. A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice.
Yu L; Bai W; Wu X; Zhang L; Zhang L; Li P; Wang F; Liu Z; Zhang F; Xu Z
Virol J; 2013 Oct; 10():301. PubMed ID: 24093752
[TBL] [Abstract][Full Text] [Related]
15. CD40 Ligand and GMCSF Coexpression Enhance the Immune Responses and Protective Efficacy of PCV2 Adenovirus Vaccine.
Li D; Huang Y; Du Q; Wang Z; Chang L; Zhao X; Tong D
Viral Immunol; 2016 Apr; 29(3):148-58. PubMed ID: 26982652
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a multi-epitope DNA vaccine against hantavirus.
Zhao C; Sun Y; Zhao Y; Wang S; Yu T; Du F; Yang XF; Luo E
Hum Vaccin Immunother; 2012 Feb; 8(2):208-15. PubMed ID: 22426376
[TBL] [Abstract][Full Text] [Related]
17. Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct Virus.
Ji X; Ren Z; Xu N; Meng L; Yu Z; Feng N; Sang X; Li S; Li Y; Wang T; Zhao Y; Wang H; Zheng X; Jin H; Li N; Yang S; Cao J; Liu W; Gao Y; Xia X
Viruses; 2016 Apr; 8(4):115. PubMed ID: 27110810
[TBL] [Abstract][Full Text] [Related]
18. Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV.
Liu R; Lv Y; Sun W; Li M; Ge N; Zhu C; Ding Y; Liu Z; Ma R; Huang Y; Hou S; Ying Q; Gu T; Wang F; Nie L; Wang Y; Huang W; Shu J; Wu X
Virus Res; 2023 Sep; 334():199149. PubMed ID: 37329903
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity of novel hantavirus isolate and antigenicity and immunogenicity of novel strain-based inactivated vaccine.
Liu YY; Xu YQ; Zhong Y; Wei F; Ling JX; Li JL; Yang L; Quan FY; Chen SL; Luo F; Hou W; Yang ZQ; Chen LJ; Xiong HR
Vaccine; 2023 Nov; 41(49):7482-7490. PubMed ID: 37953099
[TBL] [Abstract][Full Text] [Related]
20. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization.
Xu Z; Wei L; Wang L; Wang H; Jiang S
Biochem Biophys Res Commun; 2002 Nov; 298(4):552-8. PubMed ID: 12408987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]